Literature DB >> 20569763

Diabetes and coronary heart disease as risk factors for mortality in older adults.

Mercedes R Carnethon1, Mary L Biggs, Joshua Barzilay, Lewis H Kuller, Dariush Mozaffarian, Kenneth Mukamal, Nicholas L Smith, David Siscovick.   

Abstract

BACKGROUND: Type 2 diabetes has been described as a coronary heart disease (CHD) "risk equivalent." We tested whether cardiovascular and all-cause mortality rates were similar between participants with prevalent CHD vs diabetes in an older adult population in whom both glucose disorders and preexisting atherosclerosis are common.
METHODS: The Cardiovascular Health Study is a longitudinal study of men and women (n=5784) aged > or =65 years at baseline who were followed from baseline (1989/1992-1993) through 2005 for mortality. Diabetes was defined by fasting plasma glucose > or =7.0 mmol/L or use of diabetes control medications. Prevalent CHD was determined by confirmed history of myocardial infarction, angina, or coronary revascularization.
RESULTS: Following multivariable adjustment for other cardiovascular disease risk factors and subclinical atherosclerosis, CHD mortality risk was similar between participants with CHD alone vs diabetes alone (hazard ratio [HR] 1.04, 95% confidence interval [CI], 0.83-1.30). The proportion of mortality attributable to prevalent diabetes (population-attributable risk percent=8.4%) and prevalent CHD (6.7%) was similar in women, but the proportion of mortality attributable to CHD (16.5%) as compared with diabetes (6.4%) was markedly higher in men. Patterns were similar for cardiovascular disease mortality. By contrast, the adjusted relative hazard of total mortality was lower among participants with CHD alone (HR 0.85, 95% CI, 0.75-0.96) as compared with those who had diabetes alone.
CONCLUSIONS: Among older adults, diabetes alone confers a risk for cardiovascular mortality similar to that from established clinical CHD. The public health burden of both diabetes and CHD is substantial, particularly among women. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20569763      PMCID: PMC3145803          DOI: 10.1016/j.amjmed.2009.11.023

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

1.  Use and misuse of population attributable fractions.

Authors:  B Rockhill; B Newman; C Weinberg
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

2.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

3.  Differences in prevalence of and risk factors for subclinical vascular disease among black and white participants in the Cardiovascular Health Study.

Authors:  L Kuller; L Fisher; R McClelland; L Fried; M Cushman; S Jackson; T Manolio
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-02       Impact factor: 8.311

4.  Laboratory methods and quality assurance in the Cardiovascular Health Study.

Authors:  M Cushman; E S Cornell; P R Howard; E G Bovill; R P Tracy
Journal:  Clin Chem       Date:  1995-02       Impact factor: 8.327

5.  Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.

Authors:  R de Marco; F Locatelli; G Zoppini; G Verlato; E Bonora; M Muggeo
Journal:  Diabetes Care       Date:  1999-05       Impact factor: 19.112

6.  Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study.

Authors:  L Kuller; N Borhani; C Furberg; J Gardin; T Manolio; D O'Leary; B Psaty; J Robbins
Journal:  Am J Epidemiol       Date:  1994-06-15       Impact factor: 4.897

7.  Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study.

Authors:  G S Tell; L P Fried; B Hermanson; T A Manolio; A B Newman; N O Borhani
Journal:  Ann Epidemiol       Date:  1993-07       Impact factor: 3.797

8.  Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study.

Authors:  B M Psaty; L H Kuller; D Bild; G L Burke; S J Kittner; M Mittelmark; T R Price; P M Rautaharju; J Robbins
Journal:  Ann Epidemiol       Date:  1995-07       Impact factor: 3.797

9.  Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993.

Authors:  K Gu; C C Cowie; M I Harris
Journal:  Diabetes Care       Date:  1998-07       Impact factor: 19.112

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

View more
  24 in total

1.  4th Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 12-14, 2011, Budapest, Hungary.

Authors:  Boris N Mankovsky
Journal:  Diabetes Technol Ther       Date:  2011-10-04       Impact factor: 6.118

2.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

3.  Association of Cardiometabolic Multimorbidity With Mortality.

Authors:  Emanuele Di Angelantonio; Stephen Kaptoge; David Wormser; Peter Willeit; Adam S Butterworth; Narinder Bansal; Linda M O'Keeffe; Pei Gao; Angela M Wood; Stephen Burgess; Daniel F Freitag; Lisa Pennells; Sanne A Peters; Carole L Hart; Lise Lund Håheim; Richard F Gillum; Børge G Nordestgaard; Bruce M Psaty; Bu B Yeap; Matthew W Knuiman; Paul J Nietert; Jussi Kauhanen; Jukka T Salonen; Lewis H Kuller; Leon A Simons; Yvonne T van der Schouw; Elizabeth Barrett-Connor; Randi Selmer; Carlos J Crespo; Beatriz Rodriguez; W M Monique Verschuren; Veikko Salomaa; Kurt Svärdsudd; Pim van der Harst; Cecilia Björkelund; Lars Wilhelmsen; Robert B Wallace; Hermann Brenner; Philippe Amouyel; Elizabeth L M Barr; Hiroyasu Iso; Altan Onat; Maurizio Trevisan; Ralph B D'Agostino; Cyrus Cooper; Maryam Kavousi; Lennart Welin; Ronan Roussel; Frank B Hu; Shinichi Sato; Karina W Davidson; Barbara V Howard; Maarten J G Leening; Maarten Leening; Annika Rosengren; Marcus Dörr; Dorly J H Deeg; Stefan Kiechl; Coen D A Stehouwer; Aulikki Nissinen; Simona Giampaoli; Chiara Donfrancesco; Daan Kromhout; Jackie F Price; Annette Peters; Tom W Meade; Edoardo Casiglia; Debbie A Lawlor; John Gallacher; Dorothea Nagel; Oscar H Franco; Gerd Assmann; Gilles R Dagenais; J Wouter Jukema; Johan Sundström; Mark Woodward; Eric J Brunner; Kay-Tee Khaw; Nicholas J Wareham; Eric A Whitsel; Inger Njølstad; Bo Hedblad; Sylvia Wassertheil-Smoller; Gunnar Engström; Wayne D Rosamond; Elizabeth Selvin; Naveed Sattar; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

4.  [Prevalence of undetected diabetes mellitus in invasive and interventional cardiology. Silent diabetes in the catheterization laboratory].

Authors:  R Dörr; J Stumpf; S G Spitzer; B Krosse; D Tschöpe; T Lohmann; O Schnell
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

Review 5.  Environmental endocrine disruption of energy metabolism and cardiovascular risk.

Authors:  Andrew G Kirkley; Robert M Sargis
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

6.  The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities.

Authors:  Miranda T Schram; Simone J S Sep; Carla J van der Kallen; Pieter C Dagnelie; Annemarie Koster; Nicolaas Schaper; Ronald M A Henry; Coen D A Stehouwer
Journal:  Eur J Epidemiol       Date:  2014-04-23       Impact factor: 8.082

7.  Coronary risk equivalence of diabetes assessed by SPECT-MPI.

Authors:  Donna Chelle V Morales; Sanjeev P Bhavnani; Alan W Ahlberg; Raja C Pullatt; Deborah M Katten; Donna M Polk; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2017-12-06       Impact factor: 5.952

8.  Risk factors for an atherothrombotic event in patients with diabetic macular edema treated with intravitreal injections of bevacizumab.

Authors:  Alon Tiosano; Aviel Hadad; Noam Yanculovic
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

9.  The influence of sex on cardiovascular outcomes associated with diabetes among older black and white adults.

Authors:  Varsha G Vimalananda; Mary L Biggs; James L Rosenzweig; Mercedes R Carnethon; James B Meigs; Evan L Thacker; David S Siscovick; Kenneth J Mukamal
Journal:  J Diabetes Complications       Date:  2013-12-26       Impact factor: 2.852

10.  New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population.

Authors:  Farzad Hadaegh; Nooshin Fahimfar; Davood Khalili; Farhad Sheikholeslami; Fereidoun Azizi
Journal:  Cardiovasc Diabetol       Date:  2010-12-04       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.